New treatment using RNA interference for prostate cancer
Official title: Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
Funded at Nuago Therapeutics INC · NIH-11004868 · Data updated 2026-11-12
This study is exploring a new treatment for prostate cancer that uses special molecules to target and shut down genes that help cancer cells survive, with the hope of offering a better option for patients battling this disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nuago Therapeutics INC NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 19, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 1R41CA287846-01A1 |
| Project ID | NIH-11004868 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are men diagnosed with prostate cancer who are seeking new treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those who do not have prostate cancer may not benefit from this research.
What this research studies
This research focuses on developing a novel therapeutic approach for prostate cancer using RNA interference, which targets specific genes essential for cancer cell survival. The therapy utilizes short interfering RNA molecules derived from CAG trinucleotide repeat sequences, which have shown potential in reducing cancer cell viability. By downregulating the expression of genes associated with cancer, this treatment aims to provide a more effective option for patients suffering from prostate cancer. The research is based on findings from Northwestern University and aims to address the critical need for new prostate cancer therapies.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment option that significantly improves outcomes for prostate cancer patients.
How similar studies have gone: While RNA interference has been explored in various contexts, this specific application for prostate cancer represents a novel approach that has not been extensively tested.
Where this research is happening
-
Nuago Therapeutics INC
Chicago, United States Active
Researchers
- Principal investigator: Schickel, Robert — Nuago Therapeutics INC
- Study coordinator: Schickel, Robert
Related research
Other NIH-funded projects on the same topics.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Effects of ADT on motivation and emotion in prostate cancer patients
This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.
-
Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans
A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.
-
Ethical multimodal AI platform to improve prostate cancer detection with ultrasound
A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.
-
Characterizing epigenetic targets in prostate cancer to help AR-driven cancer
A research project at MD Anderson aims to understand how epigenetic factors shape androgen receptor signaling in prostate cancer to find new ways to treat resistant forms of the disease.
-
AR and RNA-binding in prostate cancer resistance
A cancer research grant exploring how the androgen receptor’s interaction with RNA may drive treatment resistance in prostate cancer, with potential to guide new therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.